Controlling thickness in fruit fly hearts reveals new pathway for heart disease

Scientists at Sanford Burnham Prebys and Salk Institute for Biological Studies have uncovered a new role for a protein known for its role in the brain helping control feelings of hunger or satiety, as well as in the liver to aid the body in maintaining a balance of energy during fasting. The new study shows that this protein also supports the maintenance of heart structure and function, but when it is overactive it causes thickening of the heart muscle, which is associated with heart disease.

Powered by WPeMatico

Feeling judged by your doctor? You might be right

When an individual visits their doctor, they aren’t supposed to keep secrets. Unless patients are forthcoming about their symptoms, behaviors, and health-related beliefs, it’s hard for health care professionals to effectively diagnose and treat illnesses—or to advise and educate patients about how to take better care of themselves in the future.

Powered by WPeMatico

Researchers discover source of deadly fungal infections in bone marrow transplant patients

Emory researcher David Weiss has spent years studying a baffling phenomenon called heteroresistance, in which a tiny fraction of bacteria remain resistant to antibiotics, while the remainder succumb. Recently, he brought his scientific acumen to the equally deadly threat of fungal bloodstream infections in patients receiving bone marrow transplants. Bloodstream infections can be lethal in these patients, including infections from Candida parapsilosis, a species of fungi that can live in the digestive tract and occasionally make it into the bloodstream.

Powered by WPeMatico

Dr Chakrapani M takes charge as Medical Superintendent of Kasturba Medical College Hospital Attavar

Mangalore: In a notable development, Dr Chakrapani M has been appointed as the new Medical Superintendent of Kasturba Medical College Hospital, Attavar.

Dr Chakrapani, a distinguished senior medicine specialist in Dakshina Kannada, brings extensive expertise and leadership to his new role. Known for his exceptional clinical skills, he has been a pivotal figure in the region’s medical community, earning widespread respect for his contributions to the field.

A highly esteemed senior medicine doctor in Dakshina Kannada, brings a wealth of expertise and leadership experience that promises to elevate the hospital’s clinical and operational excellence. He is widely recognized for his exceptional clinical skills and has been a cornerstone of medical practice in the region. His contributions to the medical field have earned him widespread recognition and respect.

According to a PTI report, Dr B. Unnikrishnan, Dean of Kasturba Medical College, Mangalore, warmly welcomed Dr Chakrapani to his new role, stating, “With a distinguished career marked by numerous leadership positions, He has previously served as the Head of the Department of Medicine. His leadership has been pivotal in shaping and enhancing the standards of medical practice within the department and beyond. We eagerly anticipate his guidance in propelling KMC Attavar Hospital to new heights and wish him every success in his endeavours.”

Also Read:70th Anniversary: Kasturba Medical College Mangalore commemorates College Day and Awards Ceremony

Dr Chakrapani’s influence extends to his tenure as the President of the Dakshina Kannada district chapter of the Association of Physicians of India. In this role, he has made significant contributions to the medical community, fostering a spirit of collaboration and continuous improvement. As a pioneer in critical care, he has chaired the Mangalore Chapter of the Indian Society of Critical Care Medicine, drove advancements and setting new benchmarks in critical care services.

In addition to his clinical and leadership roles, He has also served as the Associate Dean of Kasturba Medical College, Mangalore. His academic contributions include mentoring generations of medical professionals, guiding three PhD scholars, and authoring 82 publications, thereby enriching the educational fabric of the institution.

His appointment as the Medical Superintendent marks a new chapter for Kasturba Medical College Hospital, Attavar. His visionary approach and dedication to medical excellence will undoubtedly enhance the hospital’s reputation as a leader in healthcare services, adds news agency PTI.

Powered by WPeMatico

Tamil Nadu Health Minister honours doctors with Medical Council Awards-2024

Chennai: Health Minister Ma
Subramanian honoured doctors with the prestigious Medical Council Awards-2024
for their exceptional contributions to the medical field at a ceremony
organized by the Tamil Nadu Medical Council on Monday.

The awards were
distributed in three categories: Eminent Medical Teacher, Specialities and Research,
and Outstanding Service in the field of socio-medical relief. A total of 10
doctors received these accolades for their dedication and excellence, reports
the Daily.

During his address at the
event, Minister Subramanian highlighted the significance of the Tamil Nadu
Medical Council Awards, which were established in 2012, drawing inspiration
from the BC Roy Awards previously given by the Medical Council of India (MCI),
now known as the National Medical Commission (NMC).

Subramanian urged the
Tamil Nadu Medical Council to consider increasing the number of awardees in the
future, emphasizing the importance of recognizing more of the state’s talented
medical professionals. He noted that approximately 1.92 lakh doctors are registered
with the TMC, underscoring the potential pool of deserving candidates for the
awards, reports The New Indian Express.

“The Union government
imposed it as it doesn’t want to see people from lower socio-economic
backgrounds becoming doctors. If students from such backgrounds become doctors,
they do service to the people,” he said. Dr N Ezhilan, MLA of the
Thousand Lights constituency, also spoke at the event, reiterating the state
government’s commitment to abolishing NEET, which has been a contentious issue
in the state’s medical education landscape.

The ceremony celebrated
the remarkable achievements and unwavering dedication of Tamil Nadu’s medical
community, inspiring future generations of healthcare professionals.

Medical
Dialogues earlier reported that the Tamil Nadu Medical Council called for nominations for the ”Medical Council Awards 2024 for Medical Excellence
from eminent eligible doctors coming under various categories in June.

The meritorious doctors among the nominations
will be selected for the “Medical Council Awards-2024 for Medical Excellence”
as per the criteria/ scoring followed by the Selection Committee of the Tamil
Nadu Medical Council. The applicant must have registered with the Tamil Nadu Medical
Council. The applicant must have unblemished Moral, Ethical, and Professional
conduct and no pending criminal cases against them.

The Tamil Nadu Medical
Council is a statutory body formed under the provisions of the Madras Medical
Registration Act of 1914. The Tamil Nadu Medical Council is responsible for issuing registrations
and licenses to the medical practitioners who possess qualifications
recognized by the Medical Council of India, New Delhi.

Powered by WPeMatico

Intermediate Hyperglycemia Linked to Higher Mortality Risk in Premature CAD Patients Undergoing PCI: Study

China: Recent research has uncovered a concerning link between intermediate hyperglycemia and increased all-cause mortality among patients with premature coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).

The study, published in Reviews in Cardiovascular Medicine, highlights the need for active glucose-lowering therapy in these patients.

Premature coronary artery disease, defined as CAD in individuals younger than 55, poses significant challenges due to its early onset and aggressive nature. PCI, a common procedure to restore blood flow in blocked coronary arteries, is frequently used to treat these patients. However, new evidence suggests that intermediate hyperglycemia—a condition where blood glucose levels are elevated but not high enough to be classified as diabetes—may significantly impact outcomes for these patients.

It remains unclear whether intermediate hyperglycemia affects the risk of mortality in premature CAD patients undergoing PCI. Considering this, Ziyou Zhou, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China, and colleagues aimed to assess the prevalence of intermediate hyperglycemia and its effect on long-term all-cause death in premature CAD patients treated with PCI.

For this purpose, the researchers retrospectively included 14,585 premature CAD patients undergoing PCI from 2007 to 2020. Patients were categorized based on their hemoglobin A1c (HbA1c) levels into three groups: normal glycemia (< 6%), intermediate hyperglycemia (6%–6.5%), and hyperglycemia (≥ 6.5%).

All-cause mortality during follow-up was defined as the primary outcome, and Cox proportional hazards regression analysis was employed to evaluate the relationship between glycemic status and this outcome.

The following were the key findings of the study:

  • Among 14,585 premature CAD patients undergoing PCI (mean age 43.6 ± 7.6 years, 28.1% female), 19.6% were diagnosed with intermediate hyperglycemia.
  • Over a median follow-up of 4.62 years, patients with hyperglycemia were correlated with higher risk (hazard ratio [HR] 1.35), while patients with intermediate hyperglycemia were associated with intermediate mortality risk from all causes (HR 1.17).

The study confirmed that compared to normal glycemia, intermediate hyperglycemia is associated with a 17% increased risk of all-cause mortality, while hyperglycemia corresponds to a 35% higher risk in premature CAD patients undergoing PCI.

“These findings underscore the importance of early HbA1c monitoring in this population to prevent adverse outcomes. Active management of blood glucose levels and setting lower HbA1c targets should be considered for these patients to improve their prognosis,” the researchers wrote.

The study’s limitations include its retrospective design, potential confounding factors, and focus solely on all-cause mortality due to data constraints.

“Further prospective studies are needed. Additionally, HbA1c variability was not assessed, and hyperglycemia was determined based on baseline levels, highlighting the need for more comprehensive research,” they concluded.

Reference:

Zhou, Ziyou, et al. “Intermediate Hyperglycemia Increases the Risk of All-Cause Mortality in Premature Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention.” Reviews in Cardiovascular Medicine, vol. 24, no. 12, 2023, p. 352.

Powered by WPeMatico

Delhi AIIMS to roll out 20-seater e-buses to enhance patient transport on campus

New Delhi: The premiere health institution, the All India Institute of Medical Sciences (AIIMS) in New Delhi is set to introduce electric buses (eBuses) with an approximate capacity of 20 seats to enhance last-mile transport from nearby metro stations and bus stops to various facilities within the campus.

This new service aims to address issues related to long walks, costly autorickshaws, and limited transport options for patients and their attendants, making travel within the campus more convenient. 

According to authorities, this e-bus service is aimed at improving connectivity and services for patients and facilitating easier travel within the campus. These eBuses (20-seaters) with modern conveniences such as air-conditioning, a low floor for energy-saving entry, and wheelchair access will be provided to AIIMS patients and their carers only, news agency ANI reported.

Also Read:Delhi AIIMS urges DMRC to enhance feeder bus services to hospital

The service will be available on every 10 minutes during peak hours (7 am – 7 pm) on regular days, and every 15 minutes on Mondays, except holidays. The e-buses will have designated stops with shelter and a call button for the convenience of patients. These buses will be equipped with CCTV cameras and GPS tracking for better security and live monitoring. A mobile application will be available for real-time tracking of buses and service feedback, and fare collection will be done through UPI/AIIMS Smart Card.

According to authorities, this will alleviate traffic congestion, and help decrease environmental pollution and carbon footprints while minimising noise pollution.

“As part of such initiatives being undertaken for providing the best patient care services to our patients, we are committed to making the patient experience at AIIMS New Delhi better every day. This initiative will not only solve the transport woes of our patients but also provide a reliable and convenient ride within the campus,” AIIMS Delhi director Dr (Prof.) M Srinivas said.

According to an ANI report, Dr (Prof.) Rima Dada, PIC, Media Cell, said, “We would like the journey for patients who are coming to our campus to be absolutely smooth and hassle-free along with their attendants. The introduction of travel packages extends a model which is shaped around moving passengers, something that for long has been an ambition for businesses in The Boring Company network.”

Powered by WPeMatico

Traces of multiple urinary metals play key role in cardiovascular disease and mortality, finds study

Higher levels of urinary metals such as cadmium, tungsten, uranium, cobalt, copper and zinc are linked to increased cardiovascular disease and mortality in a racially and ethnically diverse U.S. population, according to a new study at Columbia University Mailman School of Public Health. While it is well documented that exposure to certain metals has been associated with cardiovascular disease (CVD) and mortality, until now the evidence was limited beyond arsenic, cadmium, and lead and for a racially diverse population. The findings are published in the journal Circulation.

When analyzed together, the 6 metal-mixture including cadmium, tungsten, uranium, copper, cobalt, and zinc was associated with a 29 percent increased risk of cardiovascular disease and a 66% increased risk of death over the study follow up of 18 years. Increased risk of CVD and mortality was also identified for every metal individually.

“Our study presents the results from the largest prospective study of urinary metals and cardiovascular disease to date and supports the role of urinary metals as novel risk factors for CVD and all-cause mortality risk,” said Irene Martinez-Morata, MD, PhD, in the Department of Environmental Health Sciences at Columbia Mailman School, and lead author. “Our findings can inform risk prediction and preventive strategies to improve cardiovascular health by reducing metal exposures across diverse populations.”

Exposure to metals is widespread, The sources and routes of exposure vary, and can be exacerbated by climate change leading to the contamination of air, soil and water, and ultimately the food chain. Higher burden of metal exposures has been documented across population groups such as non-Hispanic Black, Hispanic/Latino, Chinese, and American Indians, and among communities with lower socioeconomic status, revealing that sociopolitical, historical and structural factors, contribute to disparities beyond individual-level factors such as smoking, occupation and diet. “Interventions to reduce metal exposure can particularly benefit these population groups who also suffer a higher burden of CVD mortality” adds Irene Martinez-Morata.

The American Heart Association recently recognized the toxic metals arsenic, cadmium, and lead as associated with some incidence of CVD. However, until now, studies assessing the effects of less studied metals, including biometals such as copper and zinc, and metal mixtures, more likely to mimic real life exposures, have been limited.

Using the Multi-Ethnic Study of Atherosclerosis (MESA), the researchers assessed the association of six urinary metals with CVD events and mortality from six urban and suburban U.S. communities: Baltimore City and Baltimore County, Maryland; Chicago; Forsyth County, North Carolina; Los Angeles County; Northern Manhattan and the Bronx, NYC; and St. Paul, Minnesota, in July 2000-August 2002. Urine samples were analyzed at the Trace Metals Core Laboratory at Columbia University. To assess the joint effect of urinary metals as a mixture the researchers conducted additional analyses using a machine learning approach recently developed at the Department of Biostatistics at Columbia University.

Of the population analyzed, 39 percent were non-Hispanic White, 27 percent non-Hispanic Black, 22 percent Hispanic/Latino, and 12 percent Chinese descent. Over the study follow up period, 1,162 participants developed CVD and 1,844 participants died.

After accounting for established risk factors of CVD like smoking, hypertension or diabetes, the study identified that higher levels of the mixture of cadmium, tungsten, uranium, cobalt, copper, and zinc in the urine were associated with a 29 percent and a 66 percent increased risk of CVD and mortality, respectively, over the study follow up. For individual metals, higher levels of cadmium were associated with up to 25 percent and 68 percent higher risk of CVD and mortality, respectively. Similar associations were identified for all the other metals.

“Exposure to less studied metals such as tungsten and uranium is common in the U.S. and can occur through drinking water, food, air pollution, and indoor dust,” observed Martinez. While some metals, known as biometals, like copper and zinc are needed in little amounts by our body, high levels of these metals in the urine can be harmful. “While this is an ongoing field of study, high levels of essential metals in the urine can indicate an excess in exposure or loss of body reserves of these nutrients, which can occur when the metabolism is starting to malfunction, as it occurs in early stages of cardiovascular disease.”

“Implementing policies and regulations for air pollution, drinking water and food contamination, and consumer products at the federal level, in addition to addressing community and household vulnerability factors, and individual behavioral changes can reduce exposure to metals, and we note that further analyses will help inform prevention strategies and interventions, including those directed at less studied and unregulated metals such as tungsten or cobalt” noted Martinez. “And while federal regulations for lowering maximum contaminant levels for drinking water and banning leaded gasoline, for example, have successfully reduced exposure to toxic metals such as arsenic, cadmium, and lead in water and air, much more study is needed to understand the contributions of such metals as tungsten and cobalt.”

“A strength of our study is how we assessed the association of urine metals as a mixture,” said Ana Navas-Acien, MD, PhD, professor and chair of Columbia Mailman School Department of Environmental Health Sciences. “In addition to sampling a large population size and a racially and diverse participant base, we used state-of-the-art laboratory methods – led by our Trace Metals Core Laboratory, and we analyzed outcomes over a long follow-up. However, future studies using repeated measures of urine metal levels can provide even more advanced information about exposure over time.”

“The findings underscore the importance of reducing environmental exposure to these metals, which have disproportionately affected minority and poorer communities,” says Cashell Jaquish, PhD, a genetic epidemiologist at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), and a program officer with the MESA study. “The results could lead to efforts to reduce metal exposure in our communities and thereby reduce health disparities in heart disease, the leading cause of death in this country.”

Reference:

Irene Martinez-Morata, Kathrin Schilling, Ronald A. Glabonjat, Melanie Mayer, Katlyn McGraw, Marta Galvez Fernandez, Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA), Circulation, https://doi.org/10.1161/CIRCULATIONAHA.124.069414.

Powered by WPeMatico

India Faces Higher Stroke Incidence and Prevalence Compared to High-Income Countries, study reveals

India: Over the past decade, the number of new stroke cases per year ranged from 105 to 152 for every 100,000 people, and the total number of people living with stroke ranged from 44 to 559 per 100,000 people in different parts of the country, a recent review has revealed. 

The study, published in the Indian Journal of Medical Research reports that stroke incidence and prevalence in India are higher compared to other high-income countries (HICs). The study also found that stroke incidents are particularly greater in Mumbai and Kolkata, and the early stroke mortality rate in India surpasses that of other HICs.

A stroke, also known as a brain attack, occurs when blood flow to your brain is interrupted. Global Burden of Disease study indicates stroke as the second leading cause of death. From 1970-1979 to 2000-2008 there has been a 100 % increase in the incidence of stroke in low- and middle-income countries which includes India.

The scarcity of reliable studies that could give an estimate of mortality and morbidity associated with stroke has led the researchers to conduct a schematic review of epidemiological studies on stroke conducted in India.

Sureshkumar Kamalakannan, International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom, and colleagues carried out the schematic review where they took all population-based, cross-sectional studies and cohort studies from India which reported the stroke incidence rate or cumulative stroke incidence and/or the prevalence of stroke in participants including any age group.

Researchers included studies published from 1960 to 2015 for which they used Electronic databases (Ovid, PubMed, Medline, Embase and IndMED). 10 population-based cross-sectional studies were eligible to be included out of 3079 independent titles. 

Research outcomes indicate:

  • The cumulative incidence of stroke ranged from
    105 to 152/100,000 persons per year, and the crude prevalence of stroke ranged
    from 44.29 to 559/100,000 persons in different parts of the country during the
    past decade.
  • These values were higher than those of
    high-income countries.

“High-quality, population-based epidemiological studies on stroke need to be conducted to facilitate early prevention and better rehabilitation efforts for stroke-related disabilities in the country”, researchers reported.

Reference: Kamalakannan S, Gudlavalleti ASV, Gudlavalleti VSM, Goenka S, Kuper H. Incidence & prevalence of stroke in India: A systematic review. Indian J Med Res. 2017 Aug;146(2):175-185. doi: 10.4103/ijmr.IJMR_516_15. PMID: 29265018; PMCID: PMC5761027.

Powered by WPeMatico

Serum Magnesium Levels Linked to Glycemic Control in Type 2 Diabetes Patients: Study

China: A recent observational study has unveiled a significant association between serum magnesium levels and glycemic control in individuals with type 2 diabetes (T2DM), highlighting the potential benefits of magnesium supplementation for managing blood sugar levels.

The findings, published in Diabetes, Metabolic Syndrome and Obesity, suggest that prioritizing glycemic control over weight loss is crucial for reducing the incidence of hypomagnesemia in individuals with type 2 diabetes.

Magnesium is an essential mineral involved in numerous physiological processes, including glucose metabolism and insulin function. Deficiencies in magnesium have been linked to insulin resistance and poor glycemic control, which are key challenges in managing type 2 diabetes. Therefore, diabetic patients need to ensure their serum magnesium levels remain optimal.

Against the above background, Beibei Luo, Clinical Laboratory, People’s Hospital of Yuxi City, Yunnan Province, People’s Republic of China, and colleagues focused on the relationship between glycemic control and serum magnesium in type 2 diabetes mellitus.

The retrospective, observational, cross-sectional study involved 1,694 patients from the People’s Hospital of Yuxi. Fasting blood samples were collected, and demographic characteristics of the participants were recorded. Patients were divided into two groups based on glycosylated hemoglobin (HbA1c) levels (<7% or ≥7%). A t-test was used to determine significant differences between the groups. Pearson’s correlation coefficients were calculated, while logistic regression analyzed the association between various factors and glycemic control. Additionally, linear regression assessed the relationship between serum magnesium levels and HbA1c.

The study led to the following findings:

  • Patients with poor glycemic control exhibited elevated age, low-density lipoprotein (LDL-C), fasting plasma glucose (FPG), and homeostasis model assessment (HOMA-IR) compared to those with good glycemic control.
  • Total cholesterol (TC) levels were significantly higher in patients with poor glycemic control.
  • High-density lipoprotein (HDL-C) and serum magnesium levels were lower in patients with poor glycemic control. Serum magnesium levels exhibited negative correlations with HOMA-IR (r = -0.05), HbA1c (r = -0.29), and FPG (r = -0.20).
  • Serum magnesium was significantly associated with reduced odds of glycemic control (OR = 0.0005).

“In patients with type 2 diabetes, serum magnesium levels are closely linked to glycemic control. Emphasizing glycemic control over weight loss is crucial for decreasing the risk of hypomagnesemia,” the researchers wrote.

The study limitations include not assessing daily magnesium intake due to its retrospective design, incomplete case information, and imbalance between groups with good and poor glycemic control. The study did not analyze serum magnesium’s relationship with insulin resistance. Future research will address these gaps and include more comprehensive data.

Reference:

Luo, Beibei, et al. “Association Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes.” Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, vol. 17, 2024, pp. 2823-2829.

Powered by WPeMatico